1 godz. 3 min
Ep154: Robert Ang on CRISPR to Protect Bone Marrow & Attack Cancer The Long Run with Luke Timmerman
-
- Nauka
Robert Ang, CEO of Cambridge, Mass.-based Vor Bio, on using CRISPR gene editing to alter bone marrow transplants and improve treatment of acute myeloid leukemia.
Robert Ang, CEO of Cambridge, Mass.-based Vor Bio, on using CRISPR gene editing to alter bone marrow transplants and improve treatment of acute myeloid leukemia.
1 godz. 3 min